hydroxyurea has been researched along with Thromboembolism, Venous in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxyurea treatment was not related to leukemic transformation." | 1.43 | Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms. ( Akay, OM; Andıç, N; Bolaman, AZ; Kadıköylü, VG; Ünübol, M; Yağcı, E; Yavaşoğlu, İ, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreher, S | 1 |
| Ochsenreither, S | 1 |
| Trappe, RU | 1 |
| Pabinger, I | 1 |
| Bergmann, F | 1 |
| Petrides, PE | 1 |
| Koschmieder, S | 1 |
| Matzdorff, A | 1 |
| Tiede, A | 1 |
| Griesshammer, M | 1 |
| Riess, H | 1 |
| Andıç, N | 1 |
| Ünübol, M | 1 |
| Yağcı, E | 1 |
| Akay, OM | 1 |
| Yavaşoğlu, İ | 1 |
| Kadıköylü, VG | 1 |
| Bolaman, AZ | 1 |
2 other studies available for hydroxyurea and Thromboembolism, Venous
| Article | Year |
|---|---|
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncolo
Topics: Anticoagulants; Disease Susceptibility; Drug Interactions; Female; Hemorrhage; Heparin, Low-Molecula | 2014 |
Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Hemorrhage; Humans; Hydroxyurea | 2016 |